There are currently 3 active clinical trials seeking participants for Hypoparathyroidism research studies. The states with the highest number of trials for Hypoparathyroidism participants are New York, Texas, Ohio and California.
Hypoparathyroidism Natural History
NCT05793853
Recruiting
This is a prospective three year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease. Funding Source- FDA OOPD
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
05/12/2025
Locations: Columbia University Medical Center - Harkness Pavillion, New York, New York
Conditions: Hypoparathyroidism
Register for Updates
A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA
NCT05556629
Recruiting
This main aim of this study is to check the level of knowledge and assess attitudes and behaviors of both participants and prescribing physicians regarding the risks and safe use of NATPARA. The survey will be done via internet, telephone, or paper and participants will be able to choose the method that is preferred. No study medicines will be provided to patients in this study.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/07/2025
Locations: Shire-NPS Pharmaceuticals, INC. (Shire now part of Takeda), Lexington, Massachusetts
Conditions: Hypoparathyroidism
Register for Updates
Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
NCT06531941
Recruiting
The purpose of this study is to evaluate the long-term safety and tolerability of MBX 2109 in patients with hypoparathyroidism who completed the 12-week treatment period in the Phase 2 study, MBX-2H1002.
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
11/11/2024
Locations: MBX Biosciences Investigational Site, Jacksonville, Florida +21 locations
Conditions: Hypoparathyroidism
Register for Updates